Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR plus NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

F. C. Saalfeld - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
J. Moeller - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
S. Michels - , University of Cologne (Author)
C. Grohe - , Evangelical Lung Clinic Berlin (Author)
M. Wiesweg - , University of Duisburg-Essen (Author)
C. Schubart - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
J. Alt - , Johannes Gutenberg University Mainz (Author)
F. Griesinger - , Pius-Hospital Oldenburg (Author)
D. Kauffmann-Guerrero - , Technical University of Munich (Author)
J. Kulhavy - , University of Würzburg (Author)
T. R. Overbeck - , University of Göttingen (Author)
N. Pelusi - , University of Bonn (Author)
G. Rohde - , Goethe University Frankfurt a.M. (Author)
C. Wesseler - , Asklepios Cancer Center Hamburg (Author)
I. Vathiotis - , Division of Psychological and Social Medicine and Developmental Neurosciences (Author)
R. Veluswamy - , Icahn School of Medicine at Mount Sinai (Author)
O. M. Illini - , Vienna Healthcare Grp (Author)
S. I. Rothschild - , Ctr Oncol Hematol (Author)
P. Christopoulos - , Heidelberg University (Author)
M. Wermke - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)

Title	2023 Congress of the European-Society-for-Medical-Oncology
Abbreviated title	ESMO 2023
Duration	20 - 24 October 2023
Website	https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2023
Location	IFEMA MADRID & Online
City	Madrid
Country	Spain

ORCID	/0000-0002-4095-8649/work/172086477